NCT00003056 2021-05-06
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Takeda
Phase 3 Terminated
Takeda
Merck Sharp & Dohme LLC
Teva Branded Pharmaceutical Products R&D, Inc.